Home » Topics » Regulatory » Patents

Patents
RSS

Kirin Brewery synthesizes agents for arteriosclerosis

Aug. 30, 1996

SKB claims NK3 antagonists for pulmonary disorders

Aug. 30, 1996

SKB reports on PDE IV inhibitor research

Aug. 30, 1996

AChE inhibitor isolated from Penicillium at Kitasato Institute

Aug. 30, 1996

Theratech describes new rheumatiod arthritis diagnosis

Aug. 30, 1996

Beta3-adrenoceptor agonists described by Dainippon

Aug. 30, 1996

CCK antagonists from Warner-Lambert

Aug. 30, 1996

More squalene synthase inhibitors from Pfizer

Aug. 30, 1996

Estrogenic compounds from Sankyo

Aug. 30, 1996

Potent antiinflammatory/antioxidant agents from Alcon

Aug. 30, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for May 5, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for May 5, 2026
Axsome’s Auvelity cleared for large Alzheimer’s agitation market
BioWorld
Axsome Therapeutics Inc. won U.S. FDA approval for Auvelity (AXS-05) to treat Alzheimer’s disease agitation, a condition that affects up to three-quarters of...
Sonire starts US study of cancer HIFU after $18M series A
BioWorld
Sonire Therapeutics Inc. initiated a U.S.-based Sunrise II study of Suizenji, its novel ultrasound-guided high-intensity focused ultrasound (HIFU) system designed...
How to Summit up? Dis-Harmoni on ivonescimab NSCLC phase III
BioWorld
Wall Street pundits were divided about the likely fate of ivonescimab, Summit Therapeutics Inc.’s bispecific antibody partnered with Akeso Pharmaceuticals Inc.,...